Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study

Antenatal progesterone prevents preterm birth (PTB) in women with a short cervix or prior PTB in daily vaginal or weekly injectable formulations, respectively. Neither has been tested for the indication of maternal HIV, which is associated with an elevated risk of PTB. The Vaginal Progesterone (VP)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Price, Joan T., Mabula-Bwalya, Chileshe M., Freeman, Bethany L., Carda-Auten, Jessica, Phiri, Winifreda M., Chibwe, Kasapo, Kantumoya, Patricia, Vwalika, Bellington, Stringer, Jeffrey S. A., Golin, Carol E.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7514015/
https://ncbi.nlm.nih.gov/pubmed/32970697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0238748
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki